Vivacta’s technology platform can be used to measure small and large molecules and nucleic acids. Potential applications include identification, diagnosis or monitoring of endocrine and hormonal imbalances, vitamin deficiency, infections, sepsis, kidney disease, stroke and cardiovascular disease. Diagnostic tests developed using the Vivacta system may be used as companion diagnostics, for therapeutic drug monitoring (TDM) and for therapeutic effectiveness monitoring such as the detection of anti-drug antibodies and the determination of vaccination status, as well as other personalised medicine applications.
Vivacta's diagnostic products are of particular relevance to acute care in the emergency room where the rapid delivery of diagnostic information may enable improved therapeutic care. Vivacta's diagnostic products can also provide significant advantages in decentralised settings including sub-acute hospitals, doctors' surgeries, within healthcare networks and home use. Vivacta's diagnostic products are potentially ideal for telemonitoring (telehealth) of chronic patients - generating diagnostic data locally, to allow rapid decision-making and removing time lost waiting for results to be returned from central hospital laboratories.
Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH), one of the most widely prescribed laboratory tests and the industry gold standard for immunoassays by which major diagnostic companies measure the performance of competing platforms.
Vivacta is also developing a multiple analyte cardiac panel diagnostic test for use in the emergency room and acute care settings, where there is a compelling need for rapid diagnosis of possible heart attack and related time-critical medical conditions. There are also applications for Vivacta's cardiac tests in decentralised environments, such as physician offices and homecare.
Benefits of the Vivacta point-of-care system:
- Improved clinical efficiency - test and then treat; allows immediate clinical action to be taken eg emergency room
- In physicians' offices or local clinics, allows immediate patient/physician follow-up; avoids need for secondary meetings
- Increased patient retention: patients more likely to visit local medical centre – patients referred to third party laboratories often fail to present
- Patients more likely to follow-up on results - patients often don't follow-up results sent to central laboratories
- Only a pin prick of blood required – in contrast, laboratory tests require a tube of venous blood which can dissuade patients from presenting
- Facilitates drug monitoring – Vivacta's point-of-care system simplifies and speeds achievement of patients targeted dose and provides early alert of over/underdosing
